If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

Share Price is delayed by 15 minutes
Get Live Data
1,028.00    22.00 (2.19%)
Bid:
1,026.00
Ask:
1,028.00
Spread: 2.00 (0.195%)
Market Cap: £147.29b
BNC Live PriceLast checked at - London Stock Exchange

Intraday Banco Santander Share Chart

Prospectus Exemption

23 Apr 2026 07:40

RNS Number : 6416B
Banco Santander S.A.
23 April 2026
 

 

 

 

Banco Santander, S.A. ("Banco Santander"), in accordance with the provisions of securities market legislation, hereby announces the following:

 

OTHER RELEVANT INFORMATION

 

In connection with the issuance of up to 334,809,216 new ordinary shares of Banco Santander in the context of its acquisition of Webster Financial Corporation, it is hereby noted that Banco Santander is not required to publish, and will not publish, a prospectus for the purposes of Regulation (EU) 2017/1129 of the European Parliament and of the Council of June 14, 2017, on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market and repealing Directive 2003/71/EC, as amended (the "Prospectus Regulation"). Banco Santander has elected to rely on the exemptions set forth in Article 1(4)(da) and Article 1(5)(a) of the Prospectus Regulation.

 

To that end, Banco Santander has today published on its corporate website (www.santander.com) an exemption document (the "Exemption Document"), in accordance with the requirements of Annex IX of the Prospectus Regulation. The Exemption Document has been filed with the National Securities Market Commission (Comisión Nacional del Mercado de Valores, "CNMV") and made available to the public in accordance with Article 21(2) of the Prospectus Regulation. The Exemption Document is available at https://www.santander.com/content/dam/santander-com/es/documentos/aumento-de-capital-para-la-adquisicion-de-webster/exemption-document.pdf

 

The Exemption Document does not constitute a prospectus within the meaning of the Prospectus Regulation and is not subject to review and approval under Article 20 thereof. Accordingly, it has not been reviewed or approved by the CNMV.

 

 

Boadilla del Monte (Madrid), 23 April 2026

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCIJMFTMTJTMIF
Date   Source Headline
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
16th Feb 20223:20 pmRNSForm 8.3 - Meggitt Plc
16th Feb 20223:18 pmRNSForm 8.3 - Avast Plc
15th Feb 20229:07 amRNSForm 8.3 - Sanne Group plc
10th Feb 202211:37 amRNSForm 8.3 - Avast Plc
7th Feb 20224:43 pmRNSDirector/PDMR Shareholding
3rd Feb 20222:41 pmRNSSREP Capital Requirements 2022
2nd Feb 20228:25 amRNSForm 8.3 - Avast plc
2nd Feb 20227:00 amRNS2021 results report & analyst presentation
2nd Feb 20227:00 amRNS2021 Results - Press release
1st Feb 20223:03 pmRNSNotice of 2021 Results
1st Feb 20229:22 amRNSForm 8.3 - Avast Plc
26th Jan 20221:51 pmRNSForm 8.3 - Avast Plc
25th Jan 20221:40 pmRNSForm 8.3 - Avast plc
14th Jan 20224:16 pmRNSForm 8.3 - Ultra Electronics Holdings plc
11th Jan 202211:19 amRNSForm 8.3 - Meggitt plc
5th Jan 202211:36 amRNSForm 8.3 - Avast Plc
21st Dec 20211:24 pmRNSForm 8.3 - Avast plc
20th Dec 20212:37 pmRNSForm 8.3 - Sanne Group Plc
20th Dec 20212:20 pmRNSForm 8.3 - Meggitt Plc
17th Dec 20219:40 amRNSDirector/PDMR Shareholding
17th Dec 20217:00 amRNSRating granted by S&P Global Ratings
16th Dec 20212:46 pmRNSForm 8.3 - Meggitt Plc
14th Dec 20215:51 pmRNSBank of Spain formal notification: MREL
10th Dec 202112:02 pmRNSDirector/PDMR Shareholding
8th Dec 20217:00 amRNSFurther re Santander Mexico tender offer: results
7th Dec 20211:03 pmRNSDirector/PDMR Shareholding
30th Nov 202111:01 amRNSForm 8.3 - Meggitt Plc
30th Nov 202110:56 amRNSForm 8.3 - Ultra Electronics Holdings Plc
26th Nov 202112:05 pmRNSEnd of the Programme & 9 - 28 Nov Transactions
24th Nov 20214:41 pmRNSSecond Price Monitoring Extn
24th Nov 20214:35 pmRNSPrice Monitoring Extension
19th Nov 20211:08 pmRNSBuyback programme: transactions 12 Nov - 18 Nov
17th Nov 20211:33 pmRNSForm 8.3 - Ultra Electronics Holdings Plc
17th Nov 20211:30 pmRNSForm 8.3 - Sanne Group Plc
17th Nov 20211:28 pmRNSForm 8.3 - Meggitt Plc
15th Nov 20219:53 amRNSForm 8.3 - Avast Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.